Abstract

The Gardos channel is a Ca2+ sensitive, K+ selective channel present in several tissues including RBCs, where it is involved in cell volume regulation. Recently, mutations at two different aminoacid residues in KCNN4 have been reported in patients with hereditary xerocytosis. We identified by whole exome sequencing a new family with two members affected by chronic hemolytic anemia carrying mutation R352H in the KCNN4 gene. No additional mutations in genes encoding for RBCs cytoskeletal, membrane or channel proteins were detected. We performed functional studies on patients’ RBCs to evaluate the effects of R352H mutation on the cellular properties and eventually on the clinical phenotype. Gardos channel hyperactivation was demonstrated in circulating erythrocytes and erythroblasts differentiated ex-vivo from peripheral CD34+ cells. Pathological alterations in the function of multiple ion transport systems were observed, suggesting the presence of compensatory effects ultimately preventing cellular dehydration in patient’s RBCs; moreover, flow cytometry and confocal fluorescence live-cell imaging showed Ca2+ overload in the RBCs of both patients and hypersensitivity of Ca2+ uptake by RBCs to swelling. Altogether these findings suggest that the ‘Gardos channelopathy’ is a complex pathology, to some extent different from the common hereditary xerocytosis.

Highlights

  • The Gardos channel is a Ca2+ sensitive, K+ selective channel present in several tissues including red blood cells (RBCs), where it is involved in cell volume regulation

  • In this paper we report a new family with two members affected by chronic hemolytic anemia associated with the R352H mutation in the KCNN4 gene encoding the Gardos channel

  • Mutation R352H is located in the calmodulin binding domain of the Gardos channel

Read more

Summary

Introduction

The Gardos channel is a Ca2+ sensitive, K+ selective channel present in several tissues including RBCs, where it is involved in cell volume regulation. To get a mechanistic link between the Gardos channel mutation, the cellular properties and eventually the clinical phenotype, we studied two novel patients carrying KCNN4 R352H mutation performing the following investigations: (a) single cell patch-clamp recordings on both RBCs and RBCs precursors, (b) measure of the activity of single ion transporters using 86Rb+ as a tracer for K+ flux experiments, (c) evaluation of intracellular ions contents and RBC glycolysis (d) Ca2+ handling by fluorescence live imaging and flow cytometry on RBCs. We found pathological alterations in the functions of multiple ion transport systems, and metabolic glycolytic impairment

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.